1,721,057 research outputs found
PATTERN OF INSULIN DELIVERY AFTER INTRAVENOUS GLUCOSE INJECTION IN MAN AND ITS RELATION TO PLASMA-GLUCOSE DISAPPEARANCE
No full text
INSULIN KINETICS AFTER PORTAL AND PERIPHERAL INJECTION OF [INSULIN[I-125] .2. EXPERIMENTS IN INTACT DOG
No full textINSULIN KINETICS AFTER PORTAL AND PERIPHERAL INJECTION OF [INSULIN[I-125] .1. DATA-ANALYSIS AND MODELING
No full textA method for retracing the putative antigen/antibody ratio of immune complexes in biological fluids.
No full textA method for retracing the putative antigen/antibody ratio of immune complexes in biological fluids.
No full text
RESPONSE TO INTRAVENOUS GLUCOSE OF PATIENTS ON MAINTENANCE HEMODIALYSIS - EFFECTS OF DIALYSIS
No full textKINETIC-ANALYSIS OF PLASMA-INSULIN DISAPPEARANCE IN NONKETOTIC DIABETIC-PATIENTS AND IN NORMAL SUBJECTS - TRACER STUDY WITH I125 INSULIN
No full textThe kinetics of plasma noradrenaline in normal and hypertensive subjects
No full text1. The kinetics of plasma noradrenaline have been determined in normal and essential hypertensive patients by intravenous injection of tritiated noradrenaline and serial mixed venous sampling. 2. The metabolic clearance rate of plasma noradrenaline in normal subjects was approximately 1 1 min-1 m-2, whereas in essential hypertensive patients it was significantly reduced to approximately 0.6 1 min-1 m-2. 3. Metabolic clearance rate was negatively correlated to mean arterial blood pressure and total peripheral resistances. 4. Particularly low values of metabolic clearance rate were found in two patients with congestive heart failure and one with phaeochromocytoma. 5. We propose that the access of plasma noradrenaline to the main removal mechanisms takes place in competition with the flow of unlabelled endogenous noradrenaline directly released by nerve endings. The slower removal of plasma noradrenaline in essential hypertension could then express a larger release of endogenous noradrenaline in this condition
- …
